Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
V288022-5mg | 5mg | In stock | $108.90 | |
V288022-10mg | 10mg | In stock | $166.90 | |
V288022-25mg | 25mg | In stock | $374.90 | |
V288022-50mg | 50mg | In stock | $698.90 | |
V288022-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,256.90 |
Kir4.1 blocker
Synonyms | 2-(2-Bromo-4-isopropylphenoxy)-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Kir4.1 potassium channel blocker (IC50= 0.97 μM). Displays 10-fold selectivity for Kir4.1 over Kir4.1/5.1 concatemeric channels and >30-fold selectivity over Kir1.1, 2.1 and 2.2. Increases urine output and urinary Na+and K+excretion in volume-loaded rats. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | CHANNEL BLOCKER |
Mechanism of action | Channel blocker of K ir4.1 |
Product Description | VU0134992 is a selective inward rectifier potassium (Kir) channel Kir4.1 blocker with IC50 of 0.97 µM. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-(2-bromo-4-propan-2-ylphenoxy)-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide |
---|---|
INCHI | InChI=1S/C20H31BrN2O2/c1-13(2)14-7-8-17(16(21)9-14)25-12-18(24)22-15-10-19(3,4)23-20(5,6)11-15/h7-9,13,15,23H,10-12H2,1-6H3,(H,22,24) |
InChi Key | OTTDLWFVHQYRDA-UHFFFAOYSA-N |
Canonical SMILES | CC(C)C1=CC(=C(C=C1)OCC(=O)NC2CC(NC(C2)(C)C)(C)C)Br |
Isomeric SMILES | CC(C)C1=CC(=C(C=C1)OCC(=O)NC2CC(NC(C2)(C)C)(C)C)Br |
PubChem CID | 1319582 |
Molecular Weight | 411.38 |
PubChem CID | 1319582 |
---|---|
ChEMBL Ligand | CHEMBL1871911 |
CAS Registry No. | 755002-90-5 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
A2219673 | Certificate of Analysis | Dec 13, 2021 | V288022 |
A2219687 | Certificate of Analysis | Dec 13, 2021 | V288022 |
A2219688 | Certificate of Analysis | Dec 13, 2021 | V288022 |
A2219711 | Certificate of Analysis | Dec 13, 2021 | V288022 |
A2219712 | Certificate of Analysis | Dec 13, 2021 | V288022 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 41.14, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 41.14, Max Conc. mM: 100 |
---|
1. Kharade SV, Kurata H, Bender AM, Blobaum AL, Figueroa EE, Duran A, Kramer M, Days E, Vinson P, Flores D et al.. (2018) Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992.. Mol Pharmacol, 94 (2): (926-937). [PMID:29895592] |